This leading provider of sterilization equipment and services boasts a defensive business that generates significant recurring revenue and offers exposure to steadily growing demand from hospitals, surgical centers, pharmaceutical manufacturers and medical-device companies. A recent acquisition promises to fuel top-line growth in the near term and over the long haul.
Shares of health insurers trade at favorable valuations because of concerns that the implementation of the Affordable Care Act will weigh on the industry's profit margins. These risks are real but overstated, giving intrepid investors a solid buying opportunity.
DISCLAIMER: Capitalist Times, LLC is a publisher of financial news and opinions and NOT a securities broker/dealer or an investment advisor. You are responsible for your own investment decisions. All information contained in our newsletters or on our website(s) should be independently verified with the companies mentioned, and readers should always conduct their own research and due diligence and consider obtaining professional advice before making any investment decision. As a condition to accessing Capitalist Times materials and websites, you agree to our Terms and Conditions of Use, available here including without limitation all disclaimers of warranties and limitations on liability contained therein. Owners, employees and writers may hold positions in the securities that are discussed in our newsletters or on our website.